Author name: Leonardo Arias

Trump’s psychedelics push a mixed blessing for neuropsychiatric companies, patients

With a greenlight for ibogaine to enter clinical testing and three unnamed products set to receive Commissioner’s National Priority Vouchers this week, it’s full speed ahead for psychedelics. But will sidestepping normal regulatory protocols actually be a net negative for the field?

Trump’s psychedelics push a mixed blessing for neuropsychiatric companies, patients Read More »

Scroll to Top